Abstract
By administering an excessive amount of iodized oil via the hepatic artery, anticancer drugs in the iodized oil flow into the portal vein through the arterioportal communication. This phenomenon permits chemotherapy against extracapsular infiltration by a hepatocellular carcinoma (HCC) nourished by the portal blood flow. From May 1983 through July 1992, 240 cases of HCC underwent transcatheter arterioportal chemoembolization (TAPCE) with more than 5 ml of iodized oil (mean, 15 ml) in our hospital. In all, 32 patients survived for more than 3 years, and the factors favoring the efficacy of TAPCE therapy were investigated. Doxorubicin (mean, 46 mg) was given to 31 patients and 20 mg mitomycin C was given to 1 patient. The patients included one Stage 1 case, 13 Stage 2 cases, 17 Stage 3 cases, and one Stage 4 case. The mean tumor size was 5.0 cm, and portal invasion was suggested in 8 cases by angiography. The tumors were divided into 5 types: 13 cases of the single nodular type (SN), 7 cases of the single nodular type with proliferation (SN-P), 3 cases of the multinodular fused type (MN-F), 5 cases of the multinodular type (MN), and 4 cases of the massive type. A complication of liver dysfunction was detected in 14 cases, and half of them were Child's class C. In all, 7 patients underwent hepatectomy and 6 received percutaneous ethanol injection after TAPCE. The treated area of TAPCE was classified as segmental, lobar, or total. Segmental and lobar administration of TAPCE yielded statistically effective results, and their tumor response rate was 86%. All of the MN-F and massive types showed a good tumor response. The incidence of intrahepatic distant metastasis was higher in the localized TAPCE group than in the total TAPCE group. Segmental and lobar TAPCE should be applied for localized infiltrating HCCs, even in cases associated with liver cirrhosis, but these methods have a limited capacity to prevent distant intrahepatic metastasis.
Similar content being viewed by others
References
Ackerman NB (1972) Experimental studies on the circulatory dynamics of intrahepatic tumor blood supply. Cancer 29: 435
Hsu HC, Wei TC, Tsang YM, Wu MZ, Lin YH, Chuang SM (1986) Histological assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer 57: 1184
Ihde DC, Matthews MJ, Makuch RW, McIntire KR, Eddy JL, Seeff LB (1985) Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival. Am J Med 78: 399
Irene OL Ng, Edward CS Lai, Matthew MT Ng, Sheung T Fan (1992) Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 70: 45
Kan Z, Ivancev K, Hägerstrand I, Chuang VP, Lunderquist A (1989) In vivo microscopy of the liver after injection of Lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol 30: 419
Kuroda C, Sakurai M, Monden M, Marukawa T, Hosoki T, Tokumaga K, Wakasa K, Okamura J, Kozuka T (1991) Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma. A study in resected cases. Cancer 67: 81
Liver Cancer Study Group of Japan (1989) The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 19: 98
Nakakuma K, Tashiro S, Uemura K, Konno T, Tanaka M, Yokoyama I (1979) An attempt for increasing effects of hepatic ligation for advanced hepatoma (in Japanese). Jpn-Dtsch Med Ber 24: 675
Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M (1983) Transcatheter embolization of hepatocellular carcinoma. Assessment of efficacy in cases of resection following embolization. Radiology 147: 401
Nakamura H, Hashimoto T, Oi H, Sawada S (1988) Iodized oil in the portal vein after arterial embolization. Radiology 167: 415
Nakamura H, Hashimoto T, Oi H, Sawada S (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170: 783
Oi H, Matsushita M, Yamazaki H, Okamura J (1992) Therapeutic effectiveness of segmental arterioportal chemoembolization via hepatic artery for localized hepatocellular carcinoma. Eur Radiol 2: 413
Raoul JL, Heresbach D, Bretagne JF, Bentue Ferrer D, Duvauferrier R, Bourguet P, Messner M, Gosselin M (1992) Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 70: 585
Sakurai M, Okamura J, Kuroda C (1984) Transcatheter chemoembolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer 54: 387
Sugihara S, Kojiro M, Nakashima T (1985) Ultrastructural study of hepatocellular carcinoma with replacing growth pattern. Acta Pathol Jpn 35: 549
Wakasa K, Sakurai M, Kuroda C, Marukawa T, Monden M, Okamura J, Kurata A (1990) Effect of transcatheter arterial embolization on the boundary architecture of hepatocellular carcinoma. Cancer 65: 913
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oi, H., Kim, T., Kishimoto, H. et al. Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma. Cancer Chemother. Pharmacol. 33 (Suppl 1), S69–S73 (1994). https://doi.org/10.1007/BF00686671
Issue Date:
DOI: https://doi.org/10.1007/BF00686671